军事知识服务平台
BISPECIFIC ANTIBODIES DIRECTED AGAINST ALPHA-FOLATE RECEPTOR

A bispecific antibody is described comprising a first antigen binding arm that binds FRa receptor and a second antigen-binding arm that binds CD3, wherein: a) the first antigen-binding arm (A) of the bispecific antibody comprises: three heavy chain complementarity determining regions (CDRs), A- VHCDR1, A-VHCDR2 and A- VHCDR3 comprising the aminoacid sequences of SEQ ID NO: 1, 2 and 3 respectively three light chain complementarity determining regions (CDRs), A- VLCDR1, A-VLCDR2 and A- VLCDR3 comprising the aminoacid sequences of SEQ ID NO: 4, 5 and 6 respectively b) the second antigen-binding arm (B) of the bispecific antibody comprises: three heavy chain complementarity determining regions (CDRs), B- VHCDR1, B-VHCDR2 and B- VHCDR3 comprising the aminoacid sequences of SEQ ID NO: 7, 8 and 9 respectively three light chain complementarity determining regions (CDRs), B- VLCDR1, B-VLCDR2 and B- VLCDR3 comprising the aminoacid sequences of SEQ ID NO: 10, 11 and 12 respectively. Furthermore, the pharmaceutical composition comprising said bispecific antibody and its pharmaceutical use are described.

申请(专利)号 IT2024000035W
申请日期 2024年12月20日
公开(公告)日 2026年7月30日
公开(公告)号 WO2026133379A8
主分类号 C07K
分类号 C07K
申请(专利权)人 FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
发明(设计)人 FIGINI, Mariangela LUISON, Elena
国别省市代码 意大利;IT